HeartFlow Reports 40% Revenue Growth in 2025, Eyes Further Expansion in 2026

Key Facts

1HeartFlow achieved 40% sales growth in 2025, with revenue surpassing $176 million.

2The company targets 25% revenue growth for 2026, reaching between $218–222 million.

3Gross margins are expected to rise to 80–81%, with mid-term upside potential to 85%.

HeartFlow has announced robust financial results for 2025, recording a 40% surge in sales with total revenue exceeding $176 million. The company's growth is primarily driven by the increasing adoption of its AI-powered cardiac diagnostic platform and FDA-cleared next-generation algorithms. Looking ahead to 2026, HeartFlow targets a 25% revenue increase, aiming for a range between $218 million and $222 million. Gross margins are also projected to strengthen, reaching 80–81% in the near term with potential upside to 85% over the medium term. This positive outlook is supported by strong Q4 momentum and an expanding proprietary CT image database for coronary artery disease diagnostics. The company's scalable business model positions it as a key player in the high-growth AI healthcare sector.